ONCOgenic GPCR Network of Excellence and Training. An #EU Marie-Curie ITN of 16 Early Stage Researchers studying CXCR4 and ACKR3 #chemokine#GPCRs in cancer
Hi everyone - we're on Twitter! ONCORNET2.0 is a #MarieCurie ITN of 16 ESRs across Europe studying #chemokine#GPCRs#CXCR4 and #ACKR3 in cancer. Our projects cover molecular dynamics, medchem, #pharmacology through to translational work. Follow us for updates from our ESRs!
Hello everyone!
I am Noemi Karsai and I'm the next in our #ESR introduction series. I'm #ESR11 and I'm originally from Hungary, currently doing my PhD at @UoNLifeSci@COMPARE_UoBUoN, UK.
My project is about compartmentalised signalling and trafficking of ACKR3 and CXCR4. In my project, I'm using Fluorescence Correlation Spectroscopy #FCS and working with BRET sensors.
Hello :)
I am here to continue the series in which all #ESRs are presenting themselves. I am Viviana Marolda and I am in my first year of PhD. I am #ESR13, originally from Italy, and currently, I am working as a PhD student in @CBMSO_CSIC_UAM, at Universidad Autonoma de Madrid.
Hey twitter!
I am @DehanComez. I am taking over the Oncornet account for a while to start a series of all #ESRs writing about themselves and their projects. I am #ESR5, originally from Turkey and right now I am working as a PhD student in @COMPARE_UoBUoN , @UniofNottingham , UK.
My project is focused on the role of #CXCR4/ACKR3 and #EGFR receptor interactions in cancer. For this, I am using bioluminescent and fluorescent tagged receptors and ligands to apply #NanoBRET assay and advanced imaging techniques.
ONCORNET2.0 is the successor to #ONCORNET. You can see some of the work of ESRs from the first ONCORNET in this special issue of @MolPharmJournal from 2019, with reviews on #CXCR4 and #ACKR3 structure and function: molpharm.aspetjournals.org/cβ¦
Hi everyone!
Public service announcement: our Marie-Curie ITN @ONCORNET1 is on Twitter! The 16 wonderful #ECRs working on the project will soon be Tweeting about #GPCR#chemokine#ECR life and #pharmacology
Please #RT & consider a follow or follow back! ππ